The threat of avian influenza human pandemic;La amenaza de una pandemia humana por gripe aviar

Medicina Clinica

Volumn 126, Issue 5, 2006, Pages 183-188

  Vaqué Rafart, Josep ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AVIAN INFLUENZA; EPIDEMIC; EVOLUTION; HUMAN; INFECTION PREVENTION; INFLUENZA VIRUS A; REVIEW; VIRUS TRANSMISSION;

EID: 33645072217     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13084540     Document Type: Article

References (59)

1. WHO. Avian influenza: assessing the pandemic threat. Ginebra: WHO/CDS/CSR/2005.29; 2005.
2. WHA. Avian influenza and human pandemic influenza. Summary report. Meeting held in Geneva, Switzerland, 7-9 November 2005. Ginebra: WHO; 2005.
3. Bertomeu DJ, Cardoner DE, Vivet DP. Patología Médica. Apuntes de las lecciones explicadas por el Dr. D. Bartolomé Robert. Barcelona: Baseda; 1894. p. 585-6.
4. Potter CW. A history of influenza. J Appl Microbiol. 2001;91:572-9.
5. Nguyen-Van-Tam J, Hampson AW. The epidemiology and clinical impact of pandemic influenza. Vaccine. 2003;21:1762-8.
6. Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-1920 «Spanish» influenza pandemic. Bull Hist Med. 2002;76:105-15.
7. Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev. 1996;18:64-76.
8. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet. 2003;362: 1733-45.
9. a ed. Barcelona: Masson; 2003. p. 331-62.
10. World Health Organization. Casos humanos confirmados de gripe aviar A (H5N1) desde el 26-12-2003 hasta 14-01-2006. (Consultado 15 enero 2006). Disponible en: http://www.who.int/csr/disease/avian_influenza/country/ cases_table_2006_01_14/en/index.html
11. Gani R, Hughes H, Fleming D, Griffin T, Medlock J, Leach S. Potential Impact of antiviral drug use during influenza pandemic. Emerg Infect Dis. 2005;11:1355-62.
12. Lazzari S, Stöhr K. Avian influenza and influenza pandemics. Bull WHO. 2004;82:242-3.
13. Osterholm MT. Preparing for the next pandemic. N Engl J Med. 2005;352:1839-42.
14. OMS. Lista de verificación de la OMS del plan de preparación para una pandemia de influenza. Ginebra: OMS, Alerta epidémica y respuesta. Programa Mundial de Influenza. WHO/CDS/CSR/GIP/2005.4; 2005.
15. Davis M. The monster at our door. The global threat of avian flu. New York: The New Press; 2005. p. 124-6.
16. Reina J. Factores de virulencia y patogenicidad en las cepas gripales (virus influenza tipo A) aviares y humanas. Enferm Infecc Microbiol Clin. 2002;20:346-53.
17. Cox NJ, Subbarao K. Global epidemiology of influenza. Annu Rev Med. 2000;51:407-21.
18. Treanor JJ. Influenza virus. En: Mandell GL, Bennet JE, Dolin R, editors. Principles and practice of infectious diseases. 6th ed. New York: Elsevier, Churchill-Livingstone; 2005. p. 2060-85.
19. Webster RG. Influenza: an emerging disease. Emerg Infect Dis. 1998;4:431-43.
20. Hayden F, Crisier A. Transmission for avian influenza viruses to and between humans. J Infec Dis. 2005;192:1311-3.
21. Olofsson S, Kumlin U, Dimock K, Arnberg N. Avian influenza and sialic acid receptors: more than meets the eye? Lancet. Infect Dis. 2005;5:184-8.
22. Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, Shortridge KF, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet. 1998;351:467-71.
23. Glezen WP, Keitel W, Taber LH, Piedra LA, Clover RD, Couch RB. Age distribution of patients with medically attended illnesses caused by sequential variants of influenza A/H1N1; comparison to age-specific infections rates, 1978-1989. Am J Epidemiol. 1991;133:296-304.
24. Echeverri Dávila B. La gripe española. La pandemia de 1918-1919. Madrid: CIS, Centro de Investigaciones Sociológicas. Colección Monografías n.° 132: 1993. p. 166.
25. Fraser C, Riley S, Anderson RM, Ferguson NM. Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci USA. 2004;101:6146-51.
26. a ed. Barcelona: Elsevier España SA; 2004. p. 2196-200.
27. Mills CE, Robins JM, Lipsitch M. Transmissibility of 1918 pandemic influenza. Nature. 2004;432:904-6.
28. Ferguson NM, Fraser C, Donnelly CA, Ghani AC, Anderson RM. Public health risk from the avian H5N1 influenza epidemic. Science. 2004;303:968-9.
29. Longini IM, Halloran ME, Nizam A, Yang Y. Containing pandemic influenza with antiviral agents. Am J Epidemiol. 2004;159:623-33.
30. Longini IM, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DAT, et al. Containing pandemic influenza at the source. Science. 2005;303:1083-7.
31. Musher DM. How contagious are common respiratory tract infections? N Engl J Med. 2003;348:1256-66.
32. Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in health care settings. Clin Infect Dis. 2003;37:1094-101.
33. WHO. Clarification. Use of masks by health-care workers in pandemic settings. Ginebra: WHO; 2005.
34. Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, Shortridge KF, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet. 1998;351:467-71.
35. Chan PK. Outbreak of avian influenza A (H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis. 2002;34(Suppl 2):S58-64.
36. CDC. Isolation of avian influenza A (H5N1) viruses from humans -Hong Kong, May-December 1997. MMWR. 1997;46:1204-7.
37. CDC. Update: Isolation of avian influenza A(H5N1) viruses from humans - Hong Kong, 1997-1998. MMWR. 1998;46:1245-47.
38. WHO. WHO Inter-country consultation. Influenza A/H5N1 in humans in Asia. Manila, May 6th-7th, 2005. WHO; 2005.
39. Keawcharoen J, Oraveerakul K, Kuiken T, Fouchier R, Amonsin A, Payungporn S, et al. Avian influenza H5N1 in tigers and leopards. Emerg Infect Dis. 2004;10:2189-91.
40. Thanawongnuwech R, Amonsin A, Tantilertcharoen R, Damrongwatanapokin S, Theamboonlers A, Payungporn S, et al. Probable tiger-to-tiger transmission of avian influenza H5N1. Emerg Infect Dis. 2005;11:699-701.
41. Sturm-Ramirez KM, Ellis T, Bousfield B, Bissett L, Dyrting K, Rehg JE, et al. Reemerging H5N1 influenza viruses in Hong Kong in 2002 are highly pathogenic to ducks. J Virol. 2004;78:4892-901.
42. Li KS, Guan Y, Wang J, Smith GJ, Xu KM, Duan L, et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature. 2004;430:209-13.
43. WHO. Evolution of H5N1 avian influenza in Asia. Emerg Infect Dis. 2005;11:1515-21.
44. Yu H, Shu Y, Hu S, Zhang H, Gao Z, Chen H, et al. The first confirmed human case of avian influenza A (H5N1) in mainland China. Lancet. 2006;367:84.
45. The Writing Committee of the WHO Consultation on Human Influenza A/H5. Avian Influenza A (H5N1) infections in humans. N Engl J Med. 2005;353:1374-85.
46. Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci. USA 2004;101:1356-61.
47. WHO. Influenza pandemic plan. The role of WHO and guidelines for national and regional planning. Ginebra: WHO; 1999.
48. Stöhr K. The Global Agenda on Influenza surveillance and control. Vaccine. 2003;21:1744-8.
49. OMS. Plan mundial de la OMS de preparación para una pandemia e influenza. Ginebra: OMS, Alerta epidémica y respuesta. Programa Mundial de Influenza. WHO/CDS/CSR/GIP/2005.5; 2005.
50. OMS. Respuesta a la amenaza de una pandemia de gripe aviar. Medidas estratégicas recomendadas. Ginebra: OMS, Enfermedades transmisibles (vigilancia y respuesta). Programa Mundial de la Gripe. WHO/CDS/CSR/GIP/2005.8; 2005.
51. Ministerio de Sanidad y Consumo. Plan nacional de preparación y respuesta ante una pandemia de gripe. Madrid: Mayo; 2005.
52. UK Health Department. UK Influenza pandemic contingency plan. London: DH/HPIH&SD; 2005.
53. HHS. Pandemic influenza plan. Washington, DC: U.S Department of Health and Human Services; 2005.
54. Webster R, Hulse D. Controlling avian flu at the source. Nature. 2005; 435:415-6.
55. Coulombier D, Ekdahl K. H5N1 influenza and the implications for Europe. BMJ. 2005;331:413-4.
56. Reina J. Inhibidores de la neuraminidadsa y su potencial utilización en la pandemia de gripe aviar. Med Clin (Barc). 2005;125:780-3.
57. Balicer RD, Huerta M, Grotto I. Tackling the next influenza pandemic. BMJ. 2004;328:1391-2.
58. Ruef C. A new influenza pandemic - Unprepared for a big threat. Infection. 2004;32:313-4.
59. Venkayya R. Press briefing on the avian flu. Consufta el 1-11-2005. Disponible en: http://www.whitehouse.gov/news/releases/2005/11/print/20051101-7. html